YHLO Innovative IFlash Series Showcased At The 2022 AACC Expo

From July 26-28, YHLO was showcased at the American Association of Clinical Chemistry 2022 Clinical Lab Expo.

From July 26-28, YHLO was showcased at the American Association of Clinical Chemistry 2022 Clinical Lab Expo. The YHLO exhibit booth featured the Chemiluminescence Immunoassay solutions that can provide labs with better efficiency and reliability. And the highly-automated Mono-test Analyzer iStar 500, the Immunofluorescence Reader Unicell and the Vision ESR Analyzer are also showcased to attendees.

The 2022 AACC Clinical Lab Expo also featured 781 exhibitors and covered 246,700 net square feet. YHLO met a lot of old friends and new friends here in the YHLO booth (#1044) and showcased the exciting total solutions for immunoassays.

More information

Details

Bao Long Da Dao & Bao Long Er Lu, Longgang, Shenzhen, Guangdong Province, China, 518118

Shenzhen Yhlo Biotech Co., Ltd.

Associated Trend items

Breaking news! YHLO received FDA 510(k) clearance

YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA.

Recently, YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA. FDA clearance for In Vitro Diagnostic (IVD) products is a crucial regulatory step in the United States. When the FDA clears an IVD product, it means that the product has undergone a thorough evaluation and sign...

More information

YHLO Newest IVDR Certificate Extended to 72 Products

In August 2022, YHLO received the newest IVDR Certificate from BSI, one of the most reputable notified bodies for medical device CE certifications.

The IVDR certificate of YHLO covers additional 58 YHLO chemiluminescent immunoassay (CLIA) detection products including TSH, Cardiolipin IgG, AMH, CA 15-3, CK-MB, HSV-1 IgG etc. Until today, YHLO has obtained IVDR CE Certificate of 72 products, covering the autoimmunity, reproductive health, tumor markers, cardiac markers, infection detection fields and so forth. The Re...

More information

YHLO's National-level Key Project Officially Launched

The "R&D of High-performance Immune On-site Rapid Diagnosis System" project is an important part of the key special task of "Diagnostic and Treatment Equipment and Biomedical Materials" of the Chinese National Key R&D Plan.

On December 16th, YHLO in collaboration with Professor Zhou Zhou from Fuwai Hospital of the Chinese Academy of Medical Sciences, has taken the lead in the initiation of the "R&D of High-performance Immune On-site Rapid Diagnosis System" project. Aligned with the "Diagnostic Devices and Biomedical Materials" key task of the Chinese National Key R&D Program, this project a...

More information

Products associated

automated immunoassay analyzer

iStar 500

Compare

Remove all

Compare up to 10 products